宫颈上皮内瘤变3级后宫颈癌风险:80,442例女性人群队列研究
这项基于人群的回顾性队列纳入80,442例CIN3女性,中位随访15.8年,共1,278,297人年。与一般女性人群相比,CIN3女性发生宫颈癌的风险增加两倍(SIR 2.29;95%CI 2.07-2.52)。CIN3诊断时年龄≥50岁者风险增加七倍,复发CIN3者风险增加九倍;37.0%发生宫颈癌的女性未完成建议的治疗后随访。
要点
- CIN3女性宫颈癌风险长期增加两倍(SIR 2.29;95%CI 2.07-2.52)。
- CIN3诊断时年龄≥50岁者风险增加七倍,复发CIN3者增加九倍。
- 37.0%发生宫颈癌的CIN3女性未完成建议的治疗后随访。
核心结论
- CIN3女性存在长期的两倍宫颈癌风险增加,即使完成治疗后随访并坚持常规筛查。
- 该风险随CIN3诊断年龄较大、随访期间进一步衰老及复发CIN3而升高。
研究设计与样本
- 基于人群的回顾性队列研究,纳入1990至2010年荷兰病理登记库(PALGA)中80,442例CIN3女性,中位随访15.8年,共1,278,297人年。
- 通过与荷兰癌症登记库链接识别治疗后至少两年发生的复发CIN3和宫颈癌,随访至2016年,计算标准化发病比(SIR)。
主要发现
- 1554例女性(1.9%)发生复发CIN3,397例女性(0.5%)发生宫颈癌。
- CIN3女性宫颈癌风险为一般女性人群的两倍(SIR 2.29;95%CI 2.07-2.52)。
- CIN3诊断时年龄≥50岁者宫颈癌风险增加七倍,复发CIN3者增加九倍。
- 随访长达20年的风险增加似乎主要归因于衰老。
- 37.0%在CIN3后发生宫颈癌的女性未完成建议的治疗后随访。
临床怎么用
- 对CIN3治疗后女性应长期随访,尤其关注诊断时年龄≥50岁及复发CIN3者。
- 需关注治疗后随访依从性,未完成随访者宫颈癌风险可能更高。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the risk of cervical cancer in women with a history of cervical intraepithelial neoplasia (CIN) grade 3 and to review the compliance with post-treatment follow-up. METHODS: A population-based retrospective cohort study including 80,442 women with a median follow-up of 15.8 years, and 1,278,297 person years. Women with CIN3 between 1990 and 2010 were identified from the Dutch Pathology Registry (PALGA) and linked to the general female population from the Netherlands Cancer Registry. Cases of recurrent CIN3 and cervical cancer, defined as occurrence minimally two years post-treatment, were identified until 2016. Standardized incidence ratios (SIRs) were calculated for the risk of cervical cancer. RESULTS: 1554 women (1.9%) developed recurrent CIN3 and 397 women (0.5%) cervical cancer. Women with CIN3 were associated with a twofold increased risk of cervical cancer (SIR 2.29; 95%CI 2.07-2.52) compared with the general female population. Women aged ≥50 years during CIN3 diagnosis had a sevenfold and women with recurrent CIN3 a ninefold increased risk of developing cervical cancer. The increased risk up to 20 years of follow-up seems to be mostly attributable to ageing. 37.0% of women who developed cervical cancer after CIN3 did not complete the advised post-treatment follow-up. CONCLUSIONS: Women with CIN3 have a long-lasting twofold increased risk of developing cervical cancer, even when they complete the post-treatment follow-up and adhere to the regular screening program. This risk increases with CIN3 diagnosis at older age, further ageing during follow-up and in women with recurrent CIN3. Studies on optimizing follow-up strategies are warranted.
引用
- Loopik DL, IntHout J, Ebisch RMF, et al. The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women. Gynecol Oncol. 2020. PMID: 31973912. doi:10.1016/j.ygyno.2020.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。